TWiV 1008: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Virus variant\xa0clinical performance of a SARS-CoV-2 rapid antigen test (CID)
- Ventilation in\xa0buildings\xa0(CDC)
- COVID-19 mortality\xa0among SSRI users (CMI)
- Risk of post-acute sequelae of SARS-CoV-2 infection associated with\xa0sleep apnea\xa0(SLEEP)
- Trajectories\xa0of the evolution of post COVID-19 condition (IJID)
- Efficacy of\xa0cognitive behavioral therapy\xa0targeting fatigue following COVID-19 (CAD)
- Contribute to our\xa0FIMRC fundraiser at PWB
- Letters read\xa0on TWiV 1008
- Timestamps by\xa0Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv